Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
Key facts
- Where
- Portland, Egyesült ÁllamokSee the site
Where in Egyesült Államok
- Oregon Health Science UniversityPortland, Egyesült ÁllamokTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Oregon Health and Science University
- Trial code
- NCT06461962
- Record updated
- 2026. október 22.
- Original description
The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.Read full original descriptionShow less
The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.
Inclusion: Patient-defined regular use of methamphetamine in the last year; Any methamphetamine use in the past 30 days; Age 18 years or older; No client-reported diagnosis of heart failure; Able to communicate in English; Screen positive for potential methamphetamine-associated heart failure (MAHF) defined as B type natriuretic peptide (BNP) ≥50 pg/ml, or QRS width ≥120ms, or presence of any clinical heart failure symptoms.
Exclusion: Self-reported engagement in medical care for heart failure in past 6 months; Actively taking medications for heart failure.